| Sophia Genetics S.A.. (4/11/19). "Press Release: Sophia Genetics Achieves CE-IVD Milestone for Its Solid Tumor Solution for Accurate Cancer Detection". Lausanne. |
2019-04-11 |
| Novartis AG. (4/4/19). "Press Release: Novartis Updates on the Migraine Collaboration with Amgen". Basel. |
2019-04-04 |
| Roche. (4/3/19). "Press Release: Roche and Spark Therapeutics, Inc. Announce Withdrawal and Refiling of Premerger Notification and Report Form under the HSR Act and Extension of Tender Offer for Shares of Spark Therapeutics, Inc.". Basel. |
2019-04-03 |
| Lonza Group AG. (4/2/19). "Press Release: Lonza and Chr. Hansen in Joint Venture to Accelerate Momentum in Microbiome". Copenhagen & Basel. |
2019-04-02 |
| Novartis AG. (4/1/19). "Press Release: Novartis Adds Clinical and Preclinical Anti-inflammatory Programs to Portfolio with Acquisition of IFM Tre". Basel. |
2019-04-01 |
| Roche. (4/1/19). "Press Release: Roche’s Ipatasertib in Combination with Tecentriq and Chemotherapy Shows Promising Anti-tumour Activity in Triple-negative Breast Cancer in Early Phase Trial". Basel. |
2019-04-01 |
| Polyneuron Pharmaceuticals AG. (3/28/19). "Press Release: Polyneuron Raises CHF22.5 Million in Series A to Advance Novel Therapies for Autoimmune Diseases". Basel. |
2019-03-28 |
| Mologen AG. (3/27/19). "Press Release: Top Pharma Manager Stefan M. Manth, MD, to Become CEO of Mologen AG". Berlin. |
2019-03-27 |
| Roche. (3/19/19). "Press Release: FDA Approves Roche’s Tecentriq in Combination with Chemotherapy for the Initial Treatment of Adults with Extensive-stage Small Cell Lung Cancer". Basel. |
2019-03-19 |
| MorphoSys AG. (3/13/19). "Press Release: MorphoSys Presents Results for Fiscal Year 2018". Planegg. |
2019-03-13 |
| iOnctura S.A.. (3/12/19). "Press Release: iOnctura Bolsters Management Team with Senior Appointments. Michael Lahn Appointed Chief Medical Officer – Zoë Johnson Appointed Chief Scientific Officer". Geneva. |
2019-03-12 |
| Tecan Group Ltd.. (3/11/19). "Press Release: Tecan Reports Strong Second Half and a Very Successful Fiscal Year 2018". Männedorf. |
2019-03-11 |
| H. Lundbeck A/S. (3/8/19). "Press Release: Lundbeck Appoints Keld Flintholm Jørgensen as EVP and Chief Business Officer". Valby. |
2019-03-08 |
| Tecan Group Ltd.. (3/8/19). "Press Release: Qiagen and Tecan Announce Collaboration to Streamline Preanalytical Processing of QuantiFERON-TB Gold Plus". Männedorf, Germantown, MD & Hilden. |
2019-03-08 |
| Seres Therapeutics, Inc.. (3/6/19). "Press Release: Seres Therapeutics Reports Fourth Quarter and Full Year Financial Results and Provides Operational Updates". Cambridge, MA. |
2019-03-06 |
| NovoGo Therapeutics AG. (3/4/19). "Press Release: NovaGo Therapeutics Raises CHF 10 Million to Develop Regenerative Anti-Nogo Therapy for Stroke". Zurich. |
2019-03-04 |
| Neurimmune AG. (3/1/19). "Press Release: Neurimmune Appoints John Dellapa as General Counsel". Schlieren. |
2019-03-01 |
| Aimmune Therapeutics, Inc.. (2/28/19). "Press Release: Aimmune Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Provides Recent Operational Highlights". Brisbane, CA. |
2019-02-28 |
| iOnctura S.A.. (2/28/19). "Press Release: iOnctura Selected for an Oral Presentation at 2019 AACR Annual Meeting". Geneva. |
2019-02-28 |
| Syncona Ltd.. (2/26/19). "Press Release: Syncona Leads CHF 35 Million Series A Financing in Anaveon, a New Immuno-oncology Company". |
2019-02-26 |
| CRISPR Therapeutics AG. (2/25/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results". Zug & Cambridge, MA. |
2019-02-25 |
| Roche. (2/25/19). "Press Release: Roche Enters into Definitive Merger Agreement to Acquire Spark Therapeutics". Basel. |
2019-02-25 |
| Lonza Group AG. (2/25/19). "Press Release: Lonza Strengthens Pharma, Biotech and Nutrition Offerings with Aligned Structure and New Executive Committee Appointment". Basel. |
2019-02-25 |
| GT Gain Therapeutics S.A.. (2/19/19). "Press Release: Gain Therapeutics SA Announces Closing of EU 2.5 Million Series A Financing to Develop Novel Brain-Penetrant Non-Competitive Pharmacological Chaperones for Rare Lysosomal Storage Diseases and CNS Indi |
2019-02-19 |
| Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Personalised Medicine Entrectinib". Basel. |
2019-02-19 |
| CRISPR Therapeutics AG. (2/19/19). "Press Release: CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement". Zug, Cambridge, MA & Durham, NC. |
2019-02-19 |
| Roche. (2/19/19). "Press Release: FDA Grants Priority Review to Roche’s Polatuzumab Vedotin in Previously Treated Aggressive Lymphoma". Basel. |
2019-02-19 |
| AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. |
2019-02-14 |
| Arvelle Therapeutics GmbH. (2/14/19). "Press Release: Newly-Formed Arvelle Therapeutics Acquires Exclusive Rights from SK Biopharmaceuticals to Develop and Commercialize Cenobamate in Europe". Basel. |
2019-02-14 |
| Lonza Group AG. (2/13/19). "Press Release: Emerald Health Pharmaceuticals and Lonza Announce Agreement for Manufacturing of Novel Cannabinoid-Derived Drug Candidate". San Diego, CA & Basel. |
2019-02-13 |
| Novartis AG. (2/13/19). "Press Release: Novartis Receives FDA Approval for Egaten for the Treatment of Fascioliasis, a Neglected Tropical Disease". Basel. |
2019-02-13 |
| Sanofi S.A.. (2/12/19). "Press Release: Sanofi Appoints Ameet Nathwani Chief Digital Officer". Paris. |
2019-02-12 |
| Genedata AG. (2/12/19). "Press Release: Genedata Releases New Request Management System for Biotherapeutics R&D Processes". Basel. |
2019-02-12 |
| Lunaphore Technologies S.A.. (2/7/19). "Press Release: Lunaphore Launches Its First Product LabSat". Lausanne. |
2019-02-07 |
| Roche. (2/6/19). "Press Release: Roche Joins the World Federation of Hemophilia Humanitarian Aid Program". Basel. |
2019-02-06 |
| Andrew Alliance S.A.. (2/6/19). "Press Release: Andrew Alliance and Waters Corporation Partner to Provide Tailored Tools for LC-MS Research". |
2019-02-06 |
| Genedata AG. (2/5/19). "Press Release: Genedata Announces Bruker as a New Ready-to-Run Partner". Washington, DC. |
2019-02-05 |
| CureVac AG. (2/4/19). "Press Release: CureVac Appoints Stefan Mueller, Ph.D., as Vice President Preclinical". Tübingen & Boston, MA. |
2019-02-04 |
| ETH Zürich [Florian Meyer]. (2/4/19). "Press Release: Promoting Talents and New Ideas for Food Systems of the Future". |
2019-02-04 |
| Andrew Alliance S.A.. (2/4/19). "Press Release: Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement". Geneva. |
2019-02-04 |
| Genedata AG. (2/4/19). "Press Release: New Web-based Genedata Screener Showcases at SLAS2019". Washington, DC. |
2019-02-04 |
| Memo Therapeutics AG. (2/1/19). "Press Release: Memo Therapeutics Announces the Development of a Droplet Sorter Enabling Functional Antibody Screening in a High-Throughput Format". |
2019-02-01 |
| Roche. (1/31/19). "Press Release: Roche Reports Very Strong Results in 2018. Group Sales Increase 7% at Constant Exchange Rates and in Swiss Francs". Basel. |
2019-01-31 |
| Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. |
2019-01-30 |
| Clariant International AG. (1/23/19). "Press Release: Clariant Partners with ExxonMobil and Renewable Energy Group to Advance Cellulosic Biofuel Research". Muttenz, Irving, TX & Ames, IA. |
2019-01-23 |
| CRISPR Therapeutics AG. (1/22/19). "Press Release: CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies". Cambridge, MA, Boston, MA & Berlin. |
2019-01-22 |
| Scailyte AG. (1/22/19). "Press Release: Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures and Zürcher Kantonalbank as Investors". |
2019-01-22 |
| ADC Therapeutics S.A.. (1/16/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors". Lausanne. |
2019-01-16 |
| InterAx Biotech AG. (1/15/19). "Press Release: InterAx Biotech Closes Financing Round of CHF 3 Million and Appoints New Member of the Board". |
2019-01-15 |
| Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. |
2019-01-15 |
| Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement". |
2019-01-14 |
| Selexis S.A.. (1/9/19). "Press Release: Selexis Expands Strategic Immuno-Oncology Alliance with Agenus". Geneva. |
2019-01-09 |
| BC Platforms. (1/9/19). "Press Release: BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services". |
2019-01-09 |
| Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb®13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. |
2019-01-07 |
| Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". |
2019-01-07 |
| Ribon Therapeutics, Inc.. (1/4/19). "Press Release: Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer". Lexington, MA. |
2019-01-04 |
| Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. |
2019-01-04 |
| Oculis S.A.. (1/4/19). "Press Release: Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF alpha Antibody Fragment". Lausanne. |
2019-01-04 |
| CRISPR Therapeutics AG. (1/4/19). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease". Zug, Cambridge, MA & Boston, MA. |
2019-01-04 |
| Oculis S.A.. (1/4/19). "Press Release: Oculis Raises CHF15.5 Million in an Extension of Its Series B Financing Round – Total Raised CHF35.5 Million". Lausanne. |
2019-01-04 |
| ADC Therapeutics S.A.. (1/4/19). "Press Release: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors". Lausanne. |
2019-01-04 |
| UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY. |
2019-01-03 |
| ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne. |
2019-01-03 |
| Novartis AG. (12/21/18). "Press Release: Novartis Successfully Completes Acquisition of Endocyte". Basel. |
2018-12-21 |
| SHS Gesellschaft für Beteiligungsmanagement mbH. (12/20/18). "Press Release: SHS Invests in Swiss Life Science Company Evitria AG". Tübingen & Schlieren. |
2018-12-20 |
| Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. |
2018-12-20 |
| Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. |
2018-12-20 |
| Annexon Biosciences Inc.. (12/19/18). "Press Release: Annexon Biosciences Closes $75 Million Financing". South San Francisco, CA. |
2018-12-19 |
| Cellestia Biotech AG. (12/19/18). "Press Release: Cellestia Biotech AG Successfully Closes Series A Financing Round, Raising a Total of CHF 20 Million". Basel. |
2018-12-19 |
| Amgen Inc.. (12/18/18). "Press Release: Amgen and Molecular Partners Announce Strategic Collaboration In Immuno-Oncology". Thousand Oaks, CA & Schlieren. |
2018-12-18 |
| Selexis S.A.. (12/17/18). "Press Release: TeneoBio and Selexis Enter Second Services Agreement to Develop Research Cell Banks". Geneva & Menlo Park, CA. |
2018-12-17 |
| Noxxon Pharma N.V.. (12/14/18). "Press Release: Noxxon Announces Key Findings that NOX-A12 plus Keytruda Induces an Immune Response and Results in Clinical Benefit for Patients". Berlin. |
2018-12-14 |
| Santhera Pharmaceuticals Holding AG. (12/14/18). "Press Release: Santhera Raises Gross Proceeds of CHF 23.5 Million and Secures Acquisition of Option to Vamorolone Sub-license". Pratteln. |
2018-12-14 |
| ERS Genomics Ltd.. (12/13/18). "Press Release: ERS Genomics and Lonza Enter into CRISPR/Cas9 Technology Licensing Deal". Dublin. |
2018-12-13 |
| Santhera Pharmaceuticals Holding AG. (12/12/18). "Press Release: Santhera Announces Financial Results for the First Nine Months of 2018". Pratteln. |
2018-12-12 |
| AC Immune S.A.. (12/12/18). "Press Release: AC Immune and Lilly Announce License and Collaboration Agreement". Lausanne & Indianapolis, IN. |
2018-12-12 |
| SGS S.A.. (12/12/18). "Press Release: SGS Invests in Imprint Analytics, Austria". |
2018-12-12 |
| Gilead Sciences, Inc.. (12/10/18). "Press Release: Gilead Sciences Names Daniel O’Day Chairman and Chief Executive Officer". Foster City, CA. |
2018-12-10 |
| Roche. (12/10/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. |
2018-12-10 |
| AC Immune S.A.. (12/7/18). "Press Release: In Memoriam – Dr. Andreas Muhs CSO, Scientific Leader and Friend Has Passed Away". Lausanne. |
2018-12-07 |
| Qiagen N.V.. (12/6/18). "Press Release: Qiagen Announces New Collaboration to Develop Companion Diagnostic to Guide Treatment for Patients with PIK3CA-mutated Advanced Breast Cancer". Germantown, MD & Hilden. |
2018-12-06 |
| Novartis AG. (12/6/18). "Press Release: Novartis Investigational BYL719 (alpelisib) plus Fulvestrant Consistently Improved PFS in Patients with PIK3CA Mutated HR+/HER2- Advanced Breast Cancer in New SOLAR-1 Analyses". Basel. |
2018-12-06 |
| Selexis S.A.. (12/3/18). "Press Release: KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board". Durham, NC & Geneva. |
2018-12-03 |
| Argen-X N.V. (Argenx). (12/3/18). "Press Release: Argenx Enters Exclusive Global Collaboration and License Agreement with Cilag GmbH International, an Affiliate of Janssen, for Cusatuzumab (ARGX-110)". Breda & Ghent. |
2018-12-03 |
| Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug. |
2018-11-26 |
| Spark Therapeutics, Inc.. (11/23/18). "Press Release: European Commission Approves Spark Therapeutics’ Luxturna (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations". Philadeliphia, |
2018-11-23 |
| Novartis AG. (11/23/18). "Press Release: Novartis Announces Landmark EU Approval for One-time Gene Therapy Luxturna to Restore Vision in People with Rare Inherited Retinal Disease". Basel. |
2018-11-23 |
| Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolone". Pratteln & Allschwil. |
2018-11-21 |
| Santhera Pharmaceuticals Holding AG. (11/21/18). "Press Release: Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million". Pratteln & Allschwil. |
2018-11-21 |
| Lonza Group Ltd.. (11/15/18). "Press Release: Lonza and Sartorius Stedim Biotech Modify Relationship for Supply of Cell Culture Media". Basel & Aubagne. |
2018-11-15 |
| NBE Therapeutics AG. (11/15/18). "Press Release: Dr. Anthony Tolcher Joins the Scientific Advisory Board of NBE Therapeutics". Basel. |
2018-11-15 |
| Roivant Sciences GmbH. (11/13/18). "Press Release: Roivant Sciences Announces $200 Million Investment Round". Basel & London. |
2018-11-13 |
| Amal Therapeutics S.A.. (11/12/18). "Press Release: Amal Therapeutics Finalises €29 Million (CHF 33.2 Million) Series B Round". Geneva. |
2018-11-12 |
| Aimmune Therapeutics, Inc.. (11/12/18). "Press Release: Aimmune Therapeutics Announces Additional Equity Investment by Nestlé Health Science". Brisbane, CA. |
2018-11-12 |
| CRISPR Therapeutics AG. (11/9/18). "Press Release: CRISPR Therapeutics and MaxCyte Expand Clinical and Commercial License Agreement into Oncology". Zug, Cambridge, MA & Gaithersburg, MD. |
2018-11-09 |
| CRISPR Therapeutics AG. (11/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results". Zug & Cambridge, MA. |
2018-11-07 |
| Genedata AG. (11/6/18). "Press Release: Sartorius Stedim Cellca Licenses Genedata Bioprocess to Streamline Development Operations". Basel. |
2018-11-06 |
| Neurimmune AG. (11/1/18). "Press Release: Neurimmune Appoints Natascha Schill as VP Project and Alliance Management". Schlieren. |
2018-11-01 |
| Argen-X N.V. (Argenx). (11/1/18). "Press Release: Argenx Announces New Cusatuzumab (ARGX-110) AML Data in Abstracts Published in Connection with 60th American Society of Hematology Annual Meeting and Exposition". Breda & Ghent. |
2018-11-01 |
| Idorsia Ltd.. (10/23/18). "Press Release: Idorsia Announces that Simon Jose Is to Join the Company as Chief Commercial Officer". Alschwil. |
2018-10-23 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2011.jpg){kind=logo}
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lsus-life-sciences-usa-com-beta.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [MSC] Mass-Spec-Capital.com – The Mass Spectrometry Web Portal 120x600px](/banner/iito-20181119-120-600-msc-mass-spec-capital-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
